279 related articles for article (PubMed ID: 34269678)
21. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors.
Ciruela F; Burgueño J; Casadó V; Canals M; Marcellino D; Goldberg SR; Bader M; Fuxe K; Agnati LF; Lluis C; Franco R; Ferré S; Woods AS
Anal Chem; 2004 Sep; 76(18):5354-63. PubMed ID: 15362892
[TBL] [Abstract][Full Text] [Related]
22. The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons.
Borroto-Escuela DO; Ferraro L; Beggiato S; Narváez M; Fores-Pons R; Alvarez-Contino JE; Wydra K; Frankowska M; Bader M; Filip M; Fuxe K
Pharmacol Rep; 2021 Aug; 73(4):1096-1108. PubMed ID: 34426901
[TBL] [Abstract][Full Text] [Related]
23. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
24. State-dependent Lipid Interactions with the A2a Receptor Revealed by MD Simulations Using In Vivo-Mimetic Membranes.
Song W; Yen HY; Robinson CV; Sansom MSP
Structure; 2019 Feb; 27(2):392-403.e3. PubMed ID: 30581046
[TBL] [Abstract][Full Text] [Related]
25. A
Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
[TBL] [Abstract][Full Text] [Related]
26. Functional Expression of Adenosine A
Jain AR; Robinson AS
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604732
[TBL] [Abstract][Full Text] [Related]
27. Delineating the conformational landscape of the adenosine A
Huang SK; Pandey A; Tran DP; Villanueva NL; Kitao A; Sunahara RK; Sljoka A; Prosser RS
Cell; 2021 Apr; 184(7):1884-1894.e14. PubMed ID: 33743210
[TBL] [Abstract][Full Text] [Related]
28. Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain.
Fernández-Dueñas V; Bonaventura J; Aso E; Luján R; Ferré S; Ciruela F
Curr Neuropharmacol; 2022; 20(6):1035-1045. PubMed ID: 34736381
[TBL] [Abstract][Full Text] [Related]
29. Targeting adenosine A
Congreve M; Brown GA; Borodovsky A; Lamb ML
Expert Opin Drug Discov; 2018 Nov; 13(11):997-1003. PubMed ID: 30336706
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Conformation Specific Thermostabilizing Mutations for Class A G Protein-Coupled Receptors.
Jana S; Ghosh S; Muk S; Levy B; Vaidehi N
J Chem Inf Model; 2019 Sep; 59(9):3744-3754. PubMed ID: 31408606
[TBL] [Abstract][Full Text] [Related]
31. Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.
Belikoff B; Hatfield S; Sitkovsky M; Remick DG
Shock; 2011 Apr; 35(4):382-7. PubMed ID: 21192284
[TBL] [Abstract][Full Text] [Related]
32. Ligand modulation of sidechain dynamics in a wild-type human GPCR.
Clark LD; Dikiy I; Chapman K; Rödström KE; Aramini J; LeVine MV; Khelashvili G; Rasmussen SG; Gardner KH; Rosenbaum DM
Elife; 2017 Oct; 6():. PubMed ID: 28984574
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced and A2A adenosine receptor-independent T-cell suppression is short lived and easily reversible.
Ohta A; Madasu M; Subramanian M; Kini R; Jones G; Choukèr A; Ohta A; Sitkovsky M
Int Immunol; 2014 Feb; 26(2):83-91. PubMed ID: 24150242
[TBL] [Abstract][Full Text] [Related]
34. Adenosine A(2A) receptors assemble into higher-order oligomers at the plasma membrane.
Vidi PA; Chen J; Irudayaraj JM; Watts VJ
FEBS Lett; 2008 Dec; 582(29):3985-90. PubMed ID: 19013155
[TBL] [Abstract][Full Text] [Related]
35. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
36. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
[TBL] [Abstract][Full Text] [Related]
37. CD73-Mediated Formation of Extracellular Adenosine Is Responsible for Adenosine A
Simões AP; Gonçalves FQ; Rial D; Ferreira SG; Lopes JP; Canas PM; Cunha RA
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361618
[TBL] [Abstract][Full Text] [Related]
38. Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.
Bruzzese A; Dalton JAR; Giraldo J
PLoS Comput Biol; 2020 Apr; 16(4):e1007818. PubMed ID: 32298258
[TBL] [Abstract][Full Text] [Related]
39. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
